Posts - Anticoagulant Therapy

Nov 13, 2019 12:45am
From Maureen Tacke, Program Manager, Lab, Hematology/Coagulation, St. Luke's Health System: Our institution is working towards a conversion to Anti-Xa monitoring for patients on UFH , however, our pharmacy group has a question. What are other facilities doing if a patient presents, needs UFH , and is already on a DOAC (the baseline anti-Xa or PTT is elevated)?
Oct 29, 2019 12:04pm
Our November, 2019 Quick Question asks, "What may you substitute for the PT when LAC prolongs the PT
1 Comment
Oct 27, 2019 6:43pm
Click or tap here to learn the results of the AUGUSTUS trial, which shows that the combination of apixaban and a P2Y12 inhibitor such as clopidogrel is safer than Coumadin and clopidogrel, Coumadin and aspirin, or apixaban and aspirin for pos
Aug 31, 2019 9:48am
Our August, 2019 Quick Question, suggested by frequent contributor, Dave McGlasson, demonstrated the variability in clinical antithrombotic therapy bridging policies when a patient requires a procedure. Here is the question and answers provided by 70 participants: